What does life sciences solutions — cost of revenues mean?

The direct costs attributable to the production and delivery of goods sold by the Life Sciences Solutions segment, including raw materials, manufacturing labor, and shipping. This metric is essential for calculating the segment's gross margin.

Thermo Fisher Scientific (TMO) Life Sciences Solutions — Cost of revenues

Screener

Other segment segments

Laboratory Products and Biopharma Services

$4.76B+7.9%

Analytical Instruments

$876M+4.9%

Specialty Diagnostics

$657M-3.2%

Similar metrics at other companies

STRLBuilding Solutions Revenues — Cost of revenues

$83.8M+11.8%

STRLTransportation Solutions Revenues — Cost of revenues

$112.51M+7.5%

CSWContractor Solutions — Cost of revenues

$148.54M+39.5%

SHOPSubscription solutions — Cost of revenues

$148M+20.3%

SHOPMerchant solutions — Cost of revenues

$1.48B+38.2%

STRLE-Infrastructure Solutions Revenues — Cost of revenues

$435.07M+178%

Other financials

Income statement

See full

Revenue$12.0B—

Operating income$2.1B—

Net income$1.7B+7.4%

EPS (diluted)$4.68+9.3%

Balance sheet

See full

Cash & equivalents$4.1B-11.7%

Total debt$39.2B+4.6%

Total equity$52.7B+4.3%

Total assets$113.17B+11.8%

Cash flow

See full

Operating cash flow$2.1B+51.9%

CapEx-$1.2B-509%

Free cash flow$923.0M-16.5%

Valuation

See full

Market cap$213.42B+21.1%

Enterprise value$248.54B+18.9%

P/E30.6×+3.9×

P/S4.8×-0.9×

Profitability

See full

Gross margin58.3%—

Operating margin17.2%+0.8pp

Net margin15.2%+1.0pp

FCF margin15.7%-2.1pp

Returns & leverage

See full

Return on equity13.5%+0.1pp

Debt / equity0.7×0.0×

Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 11:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000097745-26-000092

(In millions)	Life Sciences Solutions	Analytical Instruments	Specialty Diagnostics	Laboratory Products and Biopharma Services	Total
Elimination of intersegment revenues					(524)
Consolidated revenues					$11,005
Segment Income
Cost of revenues	1,004	876	657	4,757
Selling, general, and administrative expenses	496	313	177	597
Research and development expenses	131	139	44	15
Other segment items	50	34	(49)	(110)
Segment income	954	355	313	778	2,399

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's life sciences solutions — cost of revenues?: Thermo Fisher Scientific (TMO) reported life sciences solutions — cost of revenues of $1B in Q1 2026.
How has Thermo Fisher Scientific's life sciences solutions — cost of revenues changed year-over-year?: Thermo Fisher Scientific's life sciences solutions — cost of revenues increased by 17.4% year-over-year, from $855M to $1B.
What does life sciences solutions — cost of revenues mean?: The direct costs attributable to the production and delivery of goods sold by the Life Sciences Solutions segment, including raw materials, manufacturing labor, and shipping. This metric is essential for calculating the segment's gross margin.